Prednisone does not directly cause shingles the way a virus causes an infection, but it raises your risk of developing shingles by weakening the immune response that keeps the shingles virus dormant. A large population-based study found that people taking systemic corticosteroids like prednisone had a 59% higher risk of shingles compared to non-users, and the risk climbed sharply with higher doses.1PubMed. Corticosteroid Use and Risk of Herpes Zoster in a Population-Based Cohort The connection is less straightforward than many people assume, because the virus, the drug, and the underlying condition being treated all play interacting roles.
You Already Carry the Virus That Causes Shingles
Shingles is caused by varicella-zoster virus, the same virus behind chickenpox. After a childhood chickenpox infection (or vaccination with the live chickenpox vaccine), the virus doesn’t leave your body. It retreats into nerve cells near the spinal cord and brain, where it can sit quietly for decades. Your immune system, specifically T cells, acts as the ongoing guard that keeps the virus locked in place.2PubMed. Varicella-zoster virus immune evasion As long as those T cells remain active and alert, the virus stays dormant. But anything that weakens T-cell function creates an opening for the virus to reactivate, travel along a nerve, and erupt as the painful, blistering rash we know as shingles.
This is why shingles tends to show up in older adults, in people with certain cancers, and in anyone whose immune system is suppressed. It isn’t a new infection you catch from someone. It’s a flare-up of a virus that’s been inside you for years, possibly since childhood. That distinction matters when we talk about prednisone, because the drug doesn’t introduce the virus. It just gives the virus room to wake up.
How Prednisone Suppresses the Immune Cells You Need Most
Prednisone belongs to a class of drugs called glucocorticoids, which are prescribed for an enormous range of conditions, from asthma and inflammatory bowel disease to lupus, rheumatoid arthritis, and organ transplant rejection. The drug works by dialing down inflammation across the body, which is why it’s so effective. But that broad suppression of the immune system includes the T cells responsible for keeping varicella-zoster virus in check.
Research on human T cells shows that glucocorticoids shut down a critical signaling chain within hours. The drug blocks the pathway that T cells use to multiply and respond to threats, by suppressing the signaling molecules T cells rely on to communicate and proliferate.3PubMed Central. The immunosuppressive effect of glucocorticoids in human primary T cells is mainly mediated via a rapid inhibition of the IL-2/IL-2R signaling axis The result is that T cells stop dividing and become less effective at patrolling for reactivating viruses. When the T cells responsible for keeping varicella-zoster dormant are weakened, the virus can reactivate and begin replicating along nerve fibers.
How Much the Risk Goes Up
The clearest picture of the risk comes from a population-based cohort study that followed a large group of adults and tracked corticosteroid prescriptions alongside shingles diagnoses. People who used systemic corticosteroids had a 59% higher risk of developing shingles compared to people who never used them. But that average masks a steep dose-response relationship. Those who took lower cumulative doses (under 500 mg of prednisolone equivalents) had about a 32% increase in risk, while those at 500 to 1,000 mg saw a 74% increase, and those above 1,000 mg saw an 80% increase.1PubMed. Corticosteroid Use and Risk of Herpes Zoster in a Population-Based Cohort
Multiple registries of rheumatoid arthritis patients paint a consistent picture with somewhat higher numbers, which makes sense given that these patients already have an immune system under stress. In a German registry of over 5,000 RA patients, daily prednisone doses of 10 mg or more were linked to roughly two and a half times the risk of shingles. A separate large collaboration found that a baseline daily dose of 10 mg or more was associated with about double the risk, and a third registry pegged the threshold a bit lower, finding increased risk at daily doses of at least 7.5 mg.4PubMed Central. Infection Risk and Safety of Corticosteroid Use At lower doses, the added risk was minimal or not detectable. The message across all of these studies is consistent: the higher the dose and the longer you take it, the more the risk climbs.
The Risk Spikes Right After You Start
One of the most striking findings from the population-based cohort study is what happens in the weeks immediately after filling a corticosteroid prescription. In the first month after a single course of systemic corticosteroids, the risk of shingles jumped roughly sixfold compared to non-users.1PubMed. Corticosteroid Use and Risk of Herpes Zoster in a Population-Based Cohort By the third month after the prescription ended, the risk had dropped back down to baseline levels.
This timing pattern has practical implications. If you’ve been prescribed a short “burst” of prednisone for, say, a bad asthma flare or a bout of poison ivy, you’re most vulnerable to shingles in the weeks right around that course. Most people don’t think of a five-to-ten-day steroid prescription as a major immune event, but the data suggest it temporarily creates a real window of vulnerability. The reassuring flip side is that the effect is reversible. Once you stop the drug and your immune system recovers, your risk returns to where it started.
When the Underlying Condition Also Raises Your Risk
This is where things get tricky for patients and doctors alike. Many of the conditions that lead to a prednisone prescription, like lupus, rheumatoid arthritis, and inflammatory myopathies, are themselves associated with higher rates of shingles. In a study that followed nearly 1,500 rheumatic disease patients who were not on biologic or targeted therapies, almost 15% developed at least one episode of shingles over about ten years of follow-up. Lupus and inflammatory myopathies carried the highest rates.5PubMed. Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies
Asthma tells a similar story from a different angle. A systematic review and meta-analysis found that people with asthma who used systemic corticosteroids had higher shingles risk than those who did not, but even the use of inhaled corticosteroids combined with other asthma medications appeared to nudge the risk upward.6European Respiratory Journal. Global herpes zoster burden in adults with asthma: a systematic review and meta-analysis Disentangling the effect of the drug from the effect of the disease is genuinely difficult. A person with severe lupus taking 20 mg of prednisone daily faces shingles risk from both directions, and the two risks probably compound each other rather than simply adding together.
This is worth understanding because it means you shouldn’t assume that switching off prednisone will completely eliminate your elevated shingles risk. If your underlying condition involves chronic immune dysregulation, some of that extra risk will remain even if you stop the steroid.
Getting Vaccinated While on Prednisone
The good news is that a highly effective shingles vaccine exists. The recombinant zoster vaccine (sold as Shingrix) is not a live vaccine, which is a critical distinction. Older shingles vaccines used a weakened live virus, and those were outright unsafe for people on significant immunosuppressive therapy. The FDA advises against giving live or live-attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids, generally defined as 10 mg or more of prednisone equivalent daily or a cumulative dose exceeding 700 mg over three months.7Hematology ASH Education Program. Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases
Because the recombinant vaccine contains no live virus, it can be given to people on immunosuppressive therapy. The Advisory Committee on Immunization Practices recommends it for people on low-dose immunosuppression, including those taking less than 20 mg of prednisone daily or using inhaled or topical steroids.8Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines The vaccine still works in people taking corticosteroids, though not quite as well. A real-world effectiveness study found the vaccine was about 65% effective in people who had received corticosteroids before vaccination, compared to about 77% in those who had not.9PubMed Central. Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting That’s a meaningful drop but still substantial protection, and it underscores why getting vaccinated before starting long-term corticosteroid therapy is ideal when the timing allows it.
If you’re already on prednisone and haven’t been vaccinated, the question of timing is worth raising with your doctor. Vaccination when your dose is at its lowest, or during a gap in treatment, could improve the immune response. But waiting for the perfect moment shouldn’t mean never getting vaccinated at all. Partial protection is far better than none, especially for someone whose immune system is already compromised.
The Odd Role of Steroids in Treating Shingles Complications
Here’s a wrinkle that catches many people off guard. While prednisone increases the risk of developing shingles in the first place, corticosteroids have actually been studied as a treatment for one of shingles’ most feared complications: postherpetic neuralgia, the persistent nerve pain that can linger for months or years after the rash has healed.
One early randomized trial of 40 patients with severe shingles found that those treated with prednisolone at 40 mg daily (tapered over four weeks) developed lasting nerve pain at a much lower rate than those given a non-steroid comparison drug. Only about 15% of the steroid-treated group experienced postherpetic neuralgia, compared to 65% of the comparison group, and the pain in the steroid group resolved faster.10British Journal of Dermatology. Do corticosteroids prevent post‐herpetic neuralgia? That sounds like a clear win, but the broader evidence hasn’t held up as neatly. A Cochrane systematic review that pooled available trials found the evidence very uncertain. The review concluded that it remains unclear whether oral corticosteroids given during an active shingles episode actually prevent postherpetic neuralgia at six months, citing serious limitations in the quality of available studies.11PubMed Central. Corticosteroids for preventing postherpetic neuralgia
So the situation is genuinely paradoxical. Corticosteroids can trigger shingles by weakening immune surveillance of the latent virus, yet they might also reduce the severity of complications once shingles occurs by dampening the inflammatory nerve damage that causes long-term pain. Whether the benefit outweighs the risk during an active shingles episode remains an open question, and practice varies. Some clinicians add a short steroid course alongside antiviral medication for patients with severe pain and swelling, particularly around the eye or ear. Others avoid it, reasoning that adding immunosuppression during an active viral infection is a gamble.
What Most People Get Wrong About Shingles
A global survey of more than 8,600 adults aged 50 and older found that knowledge about shingles was poor across the board. Only 3% of respondents correctly identified chickenpox as the cause of shingles, and 71% considered themselves unlikely or very unlikely to develop it.12Gerontology. Public Awareness and Knowledge of Herpes Zoster: Results of a Global Survey This matters for prednisone users because the most common misconception is that shingles is something you catch from someone else. If you don’t understand that the virus is already inside you, waiting for an opportunity, you won’t connect the dots between starting a steroid and developing a rash weeks later.
Another frequent misunderstanding is about who gets shingles. Most people think of it as an old-person disease, and age is indeed the biggest single risk factor. But younger adults on immunosuppressive medications can and do develop shingles. If you’re 35 and taking prednisone for an autoimmune condition, you are not exempt. The combination of a still-latent virus and a drug that suppresses the very cells keeping that virus dormant doesn’t care how old you are.
There’s also a widespread assumption that short steroid courses are harmless from an infection standpoint. A five-day prednisone pack for back pain or a sinus infection is so routine that neither patients nor prescribers always think about the infectious risks. Yet the data show that shingles risk jumps even after a single prescription and is highest in the first month. This doesn’t mean a short course of prednisone should be refused when it’s genuinely needed. It means you should be aware of the signs of shingles, a burning or tingling sensation on one side of the body followed by a blistering rash, during the weeks that follow. Early antiviral treatment, started within 72 hours of the rash appearing, substantially reduces the severity and duration of the episode.
Inhaled and Topical Steroids Versus Oral Prednisone
People who use steroid inhalers for asthma or steroid creams for eczema often wonder whether their risk is similar. The evidence suggests the risk is much lower with these routes of administration compared to systemic (oral or injected) corticosteroids. Inhaled steroids deliver the drug primarily to the lungs, and topical steroids stay mostly in the skin. The amount that reaches the bloodstream and affects T cells systemically is far smaller than what a 20 mg prednisone tablet delivers.
That said, the asthma meta-analysis found that even inhaled corticosteroids combined with other controller medications appeared to modestly increase shingles risk in asthma patients.6European Respiratory Journal. Global herpes zoster burden in adults with asthma: a systematic review and meta-analysis Whether that small increase comes from the inhaled steroid itself, from the severity of asthma that necessitates it, or from occasional oral steroid bursts that tend to accompany poorly controlled asthma is hard to tease apart. For most people using an inhaled steroid at standard doses, the shingles risk is not a reason to change therapy. But if you’re on high-dose inhaled steroids and also taking periodic oral prednisone courses for flares, the cumulative steroid exposure adds up.
Vaccination recommendations from the ACIP treat inhaled and topical steroids as low-risk, explicitly stating that people using these forms are appropriate candidates for the recombinant shingles vaccine without restriction.8Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines If you’ve been hesitant about the vaccine because you’re on a steroid inhaler, that concern is essentially unfounded.